Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

KalVista Pharmaceuticals (KALV) Amortizatization of Intangibles: 2014-2025

Historic Amortizatization of Intangibles for KalVista Pharmaceuticals (KALV) over the last 8 years, with Apr 2025 value amounting to $14,000.

  • KalVista Pharmaceuticals' Amortizatization of Intangibles fell 25.00% to $3,000 in Q2 2025 from the same period last year, while for Apr 2025 it was $17,000, marking a year-over-year decrease of 81.52%. This contributed to the annual value of $14,000 for FY2025, which is 84.78% down from last year.
  • Latest data reveals that KalVista Pharmaceuticals reported Amortizatization of Intangibles of $14,000 as of FY2025, which was down 84.78% from $92,000 recorded in FY2024.
  • KalVista Pharmaceuticals' 5-year Amortizatization of Intangibles high stood at $2.6 million for FY2022, and its period low was $14,000 during FY2025.
  • Over the past 3 years, KalVista Pharmaceuticals' median Amortizatization of Intangibles value was $92,000 (recorded in 2024), while the average stood at $364,667.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first spiked by 274.45% in 2022, then slumped by 90.69% in 2024.
  • Yearly analysis of 5 years shows KalVista Pharmaceuticals' Amortizatization of Intangibles stood at $685,000 in 2021, then soared by 274.45% to $2.6 million in 2022, then slumped by 61.48% to $988,000 in 2023, then plummeted by 90.69% to $92,000 in 2024, then crashed by 84.78% to $14,000 in 2025.